Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × Immune Checkpoint Inhibitors × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Dactinomycin 5 temsirolimus 4 cixutumumab 4 Sirolimus 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 X-Rays 3 Radiation 3 Phantoms, Imaging 3 Doxorubicin 3 thymoglobulin 2 fludarabine phosphate 2 eribulin 2 Vinorelbine 2 Temozolomide 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Image-Guided 2 Peripheral Blood Stem Cell Transplantation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Melphalan 2 Ifosfamide 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡